NEWS ON HEALTH CARE
-
May 22, 2020, Friday
Strides Pharma gets DGCI approval to test potential Covid-19 drug
Glenmark was the first Indian firm to get approval from regulator to conduct trials on Favipiravir tablets, which are otherwise used to treat ...
-
May 21, 2020, Thursday
Once the stock breakout, wait for the rally to sustain with decent volumes
One needs to develop strategies that provide confirmation on
-
May 21, 2020, Thursday
ut raises doubts on the trading strategies. Subsequent triggers in the
ntify is the swings with volatile volumes s
-
May 21, 2020, Thursday
Different Centre-state rules slow India Inc's bid to restart business
The Delhi government, in a major relaxation. has permitted everyone to go to office. But the Maharashtra government has gone to the other ...
-
May 21, 2020, Thursday
Confused about when to buy a stock? Here's what you need to know
One needs to first gauge the overall trend by correlating different indicators and chart patterns with price momentum.
-
January 24, 2020, Friday
MARKET WRAP: Sensex up 227 pts, mid-cap rally continues; metal stocks gain
All that happened in the markets today
-
June 12, 2018, Tuesday
One year later, pharma industry bounces back to double-digit growth in May
In May, price growth for drugs was in negative territory at (-)1 per cent
-
May 31, 2018, Thursday
Possible unit disposals wouldn't move the needle
If this is all that comes out of Allergan's strategic review, it won't be enough to satisfy angry investors and possible activists
-
May 29, 2018, Tuesday
Overall economic sentiment is positive in India, says Ajay Piramal
The investment cycle is turning for better and the overall economic sentiment is positive in the country, says Ajay Piramal
-
May 01, 2018, Tuesday
The obvious opportunity is biosimilars, says Biocon's Kiran Mazumdar-Shaw
A month ago, Biocon announced that its biosimilar insulin glargine trademarked as Semglee received marketing approval from the European ...
-
March 01, 2018, Thursday
Glenmark: Risk-reward turning favourable even as stocks hit 52-week low
Businesses in other geographies can drive growth, US challenges remain
-
September 16, 2017, Saturday
Congress Vice-President Rahul Gandhi being presented a turban
The company's US FDA approved the site at Mirfield has two dedicated API manufacturing facilities
-
July 24, 2017, Monday
Small shareholders demand seat at Alembic board
Corporate governance experts claim it could trigger a trend
-
July 19, 2017, Wednesday
Mahindra Holidays plans US acquisition
Company is assessing properties in Orlando, Las Vegas as outbound travel rises
-
June 28, 2017, Wednesday
Troubles behind it, Cadila surges aheadlkjlkjkjlkjj
Cadila hopes to double its revenue from the US in three years
-
May 18, 2017, Thursday
Outlook for Nifty remains bullish, says Sacchitanand Uttekar
Nifty outlook & trading ideas by Sacchitanand Uttekar, AVP - Technical (Equity) at Tradebulls
-
April 19, 2017, Wednesday
Aurobindo's Unit-3 gets Form 483 with six observations
BS Reporter Hyderabad, 19 AprilAurobindo Pharma Limited's formulations manufacturing facility at Bachupally in Hyderabad has received Form 483 ...
-
March 17, 2017, Friday
E-portal to keep tab on antibiotics sales
Identity of doctors prescribing any medicine & patients' profiles must be part of the database
-
January 15, 2017, Sunday
Pharma barons swallow FDA bitter pill
Combined net worth of country's top 8 pharma promoters down by Rs 42,000 crore since 2015
This is Ipad Free Banner Footer Test
Notice: Undefined variable: mediaAbsUrl in /usr2/unibs/application/modules/core/controllers/SectorController.php on line 156
